OneSource Speci.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE013P01021
  • NSEID: ONESOURCE
  • BSEID: 544292
INR
1,704.30
-24.8 (-1.43%)
BSENSE

Dec 24

BSE+NSE Vol: 1.57 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039523,
    "name": "OneSource Speci.",
    "stock_name": "OneSource Speci.",
    "full_name": "OneSource Specialty Pharma Ltd",
    "name_url": "stocks-analysis/onesource-speci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,704.30",
    "chg": -24.8,
    "chgp": "-1.43%",
    "dir": -1,
    "prev_price": "1,729.10",
    "mcapval": "19,509.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544292,
    "symbol": "ONESOURCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE013P01021",
    "curr_date": "Dec 24",
    "curr_time": "",
    "bse_nse_vol": "1.57 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 24, 2025",
    "traded_date_str": "2025 12 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/onesource-speci-10039523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is OneSource Speci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onesource-speci-fallingrising-3722373",
        "imagepath": "",
        "date": "2025-11-22 01:38:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>The stock has been under pressure over the past week, registering a decline of 6.07%, in stark contrast to the Sensex, which gained 0.79% during the same period. Over the last month, the disparity widened further, with OneSource Specialty Pharma falling 11.84% while the Sensex rose by 0.95%. This divergence highlights the stock’s relative weakness amid a generally positive market environment. Year-to-date and longer-term returns for the stock are not available, but the Sensex’s gains of 9.08% YTD and 10.47% over one year provide a benchmark for comparison, underscoring the stock’s lagging performance.</p>\n<p><strong>Technical Indicators and Trading Activity</strong></p>\n<p>On the day of 21-Nov, the stock’s intraday low touched ₹1,59..."
      },
      {
        "title": "How has been the historical performance of OneSource Speci.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-onesource-speci-3695893",
        "imagepath": "",
        "date": "2025-11-13 00:44:25",
        "description": "Answer:\nThe historical performance of OneSource Speci. shows significant fluctuations in key financial metrics over the past four years, particularly from March 2022 to March 2025.\n\nBreakdown:\nOneSource Speci. experienced a dramatic increase in net sales, rising from 128.18 Cr in March 2022 to 1,444.85 Cr in March 2025. This surge in total operating income followed a similar trend, moving from 171.92 Cr in March 2024 to 1,444.85 Cr in March 2025. However, the company's total expenditure also escalated, reaching 978.34 Cr in March 2025, up from 260.16 Cr in March 2024. Despite the growth in revenue, the operating profit (PBDIT) improved to 483.98 Cr in March 2025 from a loss of 84.01 Cr in March 2024. Nevertheless, the company reported a profit before tax of -67.07 Cr in March 2025, an improvement from -365.70 Cr in March 2024. The profit after tax also showed a slight recovery, with a loss of -17.28 Cr in M..."
      },
      {
        "title": "Why is OneSource Speci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onesource-speci-fallingrising-3691458",
        "imagepath": "",
        "date": "2025-11-12 00:28:17",
        "description": "As of 11-Nov, OneSource Specialty Pharma Ltd is experiencing a decline in its stock price, currently at Rs 1,740.00, which reflects a decrease of Rs 50.9 or 2.84%. The stock opened with a gain of 2.17% today but subsequently fell, reaching an intraday low of Rs 1,737.65, indicating volatility within the trading session. The stock has underperformed its sector by 2.71% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 59.45% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, OneSource Specialty Pharma Ltd's performance over the past week shows a decline of 4.70%, while the benchmark Sensex has increased by 0...."
      },
      {
        "title": "Why is OneSource Speci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onesource-speci-fallingrising-3597034",
        "imagepath": "",
        "date": "2025-10-06 23:54:11",
        "description": "As of 06-October, OneSource Specialty Pharma Ltd's stock price is rising, currently at 1,886.50, reflecting an increase of 80.25 or 4.44%. The stock has been gaining for the last two days, with a total return of 5.64% during this period. Despite opening with a loss of 2.02% today, it reached an intraday high of Rs 1893.85, indicating some volatility. The stock has outperformed its sector by 4.33%, although there has been a significant decline in investor participation, with delivery volume dropping by 74.03% against the five-day average. The absence of specific positive or negative factors in the dashboard limits a deeper analysis of the influences on the stock's movement.\n\nBroader Market Context: In the short term, OneSource Specialty Pharma Ltd has outperformed the benchmark Sensex, which has gained 1.77% over the past week, while the stock itself has increased by 5.32% in the same timeframe. This indicat..."
      }
    ],
    "total": 180,
    "sid": "10039523",
    "stock_news_url": "https://www.marketsmojo.com/news/onesource-specialty-pharma-10039523"
  },
  "announcements": [
    {
      "caption": "Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
      "datetime": "23-Dec-2025",
      "details": "The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on December 23 2025 for Tenshi Pharmaceuticals Pvt Ltd",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
      "datetime": "19-Dec-2025",
      "details": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on December 19 2025 for Tenshi Pharmaceuticals Pvt Ltd",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "11-Dec-2025",
      "details": "This intimation is in reference to our intimation dated 09.12.2025 where the number of shares allotted was intimated as 114562136 instead of 23000 equity shares of Re. 1/- each under ONESOURCE ESOP 2021.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is OneSource Speci. falling/rising?

2025-11-22 01:38:49

Recent Price Movement and Market Comparison

The stock has been under pressure over the past week, registering a decline of 6.07%, in stark contrast to the Sensex, which gained 0.79% during the same period. Over the last month, the disparity widened further, with OneSource Specialty Pharma falling 11.84% while the Sensex rose by 0.95%. This divergence highlights the stock’s relative weakness amid a generally positive market environment. Year-to-date and longer-term returns for the stock are not available, but the Sensex’s gains of 9.08% YTD and 10.47% over one year provide a benchmark for comparison, underscoring the stock’s lagging performance.

Technical Indicators and Trading Activity

On the day of 21-Nov, the stock’s intraday low touched ₹1,59...

Read More
stock-recommendationAnnouncement

Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

23-Dec-2025 | Source : BSE

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on December 23 2025 for Tenshi Pharmaceuticals Pvt Ltd

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

19-Dec-2025 | Source : BSE

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on December 19 2025 for Tenshi Pharmaceuticals Pvt Ltd

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

11-Dec-2025 | Source : BSE

This intimation is in reference to our intimation dated 09.12.2025 where the number of shares allotted was intimated as 114562136 instead of 23000 equity shares of Re. 1/- each under ONESOURCE ESOP 2021.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available